Actavis Pharma Inc

FDA Regulatory Profile

Actavis Pharma Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1060-2016, Class III) was initiated on March 16, 2016.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1060-2016Class IIICiprofloxacin Ophthalmic Solution (0.3% as base), Sterile, Rx only, a) 2.5 mL Bottle, b) 5 mL BottleMarch 16, 2016